Tag Archives: great3

A GREAT Day for Celiac Disease

Celiac Disease Foundation is proud to have been a funder and to participate on the Steering Committee for the FDA Gastroenterology Regulatory Endpoints and Advancement of Therapeutics (GREAT3) workshop. Conceived by Dr. Sonia Kupfer of the University of Chicago and CDF Medical Advisory Board member Dr. Daniel Leffler of Beth Israel Deaconess Medical Center, GREAT3 […]

CDF Funds FDA GREAT3 Workshop in Washington, D.C.

On March 30-31st, 2015, Celiac Disease Foundation Chief Executive Officer, Marilyn G. Geller, attended the FDA Public Workshop on Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT3) near Washington, D.C. This landmark conference addressed endpoints and outcome measures for trials for products intended to treat celiac disease and Irritable Bowel Disease. The second day […]

Marilyn’s Message March 2015

Marilyn Geller

We are making progress. I freely admit to you, however, that it isn’t enough. We are not satisfied, but please know that we are in this for the long haul. My hope is that you will stand with us by supporting CDF’s Annual Fund with a tax-deductible contribution. For 25 years, CDF has been the […]

FDA Public Workshop on Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT3), March 30-31, 2015

Celiac Disease Foundation is pleased to announce the March 30-31, 2015, U.S. Food and Drug Administration (FDA) public workshop on Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT3). This scientific meeting will address endpoints and outcome measures for clinical trials for products intended to treat adult and/or pediatric celiac disease and inflammatory bowel disease.

Marilyn’s Message February 2015

Marilyn Geller

I cannot stress enough how important your generous commitment is to our ongoing work here at Celiac Disease Foundation. I am pleased to report that we are making real progress in focusing resources and attention on celiac disease. For example, next month, the Food and Drug Administration (FDA) will be hosting a two-day meeting at […]